BRPI0607323A2 - composições e uso de polipeptìdeos e kits para a detecção de anticorpo que se liga especificamente a um polipeptìdeo - Google Patents
composições e uso de polipeptìdeos e kits para a detecção de anticorpo que se liga especificamente a um polipeptìdeoInfo
- Publication number
- BRPI0607323A2 BRPI0607323A2 BRPI0607323-9A BRPI0607323A BRPI0607323A2 BR PI0607323 A2 BRPI0607323 A2 BR PI0607323A2 BR PI0607323 A BRPI0607323 A BR PI0607323A BR PI0607323 A2 BRPI0607323 A2 BR PI0607323A2
- Authority
- BR
- Brazil
- Prior art keywords
- polypeptides
- compositions
- polypeptide
- specifically binds
- kits
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 241000191940 Staphylococcus Species 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1285—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Corynebacterium (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Mycobacteriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56938—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
Abstract
COMPOSIçõES E USO DE POLIPEPTìDEOS E KITS PARA A DETECçãO DE ANTICORPO QUE SE LIGA ESPECIFICAMENTE A UM POLIPEPTìDEO. A presente invenção fornece polipeptideos isolados que podem ser isolados partindo de um Staphylococcus spp. São também fornecidas pela presente invenção composições que incluem um ou mais dos polipeptideos e métodos para a produção e métodos para a utilização dos polipeptideos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65284305P | 2005-02-14 | 2005-02-14 | |
US60/652,843 | 2005-02-14 | ||
PCT/US2006/005058 WO2006088803A2 (en) | 2005-02-14 | 2006-02-14 | Polypeptides from staphylococcus aureus and methods of use |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0607323A2 true BRPI0607323A2 (pt) | 2009-09-01 |
BRPI0607323B1 BRPI0607323B1 (pt) | 2020-12-22 |
BRPI0607323B8 BRPI0607323B8 (pt) | 2021-05-25 |
Family
ID=36694403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0607323A BRPI0607323B8 (pt) | 2005-02-14 | 2006-02-14 | composições, usos de polipeptídeos e de anticorpos, bem como kits para a detecção de anticorpo que se liga especificamente a um polipeptídeo |
Country Status (13)
Country | Link |
---|---|
US (13) | US8007811B2 (pt) |
EP (1) | EP1853306B1 (pt) |
JP (3) | JP2008532935A (pt) |
CN (2) | CN103143006B (pt) |
AU (1) | AU2006214534B2 (pt) |
BR (1) | BRPI0607323B8 (pt) |
CA (1) | CA2597263C (pt) |
DK (1) | DK1853306T3 (pt) |
ES (1) | ES2586125T3 (pt) |
HK (1) | HK1117746A1 (pt) |
MX (1) | MX2007009828A (pt) |
NZ (4) | NZ560612A (pt) |
WO (1) | WO2006088803A2 (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5830479A (en) * | 1994-02-09 | 1998-11-03 | Willmar Poultry Company, Inc. | Active immunization using a siderophore receptor protein |
EP0749321B1 (en) * | 1994-02-09 | 2007-01-24 | Epitopix LLC | Active immunization using a siderophore receptor protein |
DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
NZ526786A (en) * | 2001-01-03 | 2006-02-24 | Willmar Poultry Co Inc | Methods for removal of lipopolysaccharides (LPS) from vaccines for non-human animals |
ES2395022T3 (es) | 2003-09-19 | 2013-02-07 | Epitopix, Llc | Polipéptidos de Campylobacter y sus métodos de uso |
ES2586125T3 (es) | 2005-02-14 | 2016-10-11 | Epitopix, Llc | Polipéptidos de Staphylococcus aureus y métodos de uso |
WO2007100580A2 (en) * | 2006-02-22 | 2007-09-07 | The Texas A & M University System | Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use |
JP5564249B2 (ja) * | 2006-06-23 | 2014-07-30 | アレシア・バイオセラピューティクス・インコーポレーテッド | 癌に関与するポリヌクレオチド配列およびポリペプチド配列 |
BRPI0921805A2 (pt) | 2008-11-03 | 2016-11-01 | Alethia Biotherapeutics Inc | anticorpos que especificamente bloqueiam a atividade biológica de um antígeno de tumor |
MX339461B (es) | 2009-03-23 | 2016-05-27 | Epitopix Llc | Polipeptidos y composiciones inmunizantes que contienen polipeptidos grampositivos y metodos de uso. |
CN106146664B (zh) | 2011-03-31 | 2021-09-07 | Adc治疗股份有限公司 | 针对肾相关抗原1的抗体及其抗原结合片段 |
SI2802351T1 (sl) | 2012-01-09 | 2019-07-31 | ADC Therapeutics SA, Biopole | Sredstva za zdravljenje trojno negativnega raka dojke |
US9169477B2 (en) | 2012-01-27 | 2015-10-27 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Compositions and methods for immunization against bacteria expressing a carbapenemase |
US10100093B2 (en) | 2013-12-31 | 2018-10-16 | Epitopix Llc | Polypeptides and immunizing compositions containing Burkholderia polypeptides and methods of use |
WO2017011340A2 (en) | 2015-07-10 | 2017-01-19 | Epitopix, Llc. | Proteins and immunizing compositions containing klebsiella proteins and methods of use |
WO2017024038A1 (en) * | 2015-08-03 | 2017-02-09 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Solar concentrator for a tower-mounted central receiver |
US10166280B2 (en) | 2016-06-08 | 2019-01-01 | Epitopix, Llc | Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use |
TWI733412B (zh) * | 2020-04-13 | 2021-07-11 | 華邦電子股份有限公司 | 具有氣隙之半導體元件及其製造方法 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4981685A (en) * | 1986-03-07 | 1991-01-01 | Utah State University Foundation | Bacterial extract vaccines for veterinary application |
US5554372A (en) | 1986-09-22 | 1996-09-10 | Emory University | Methods and vaccines comprising surface-active copolymers |
US5292869A (en) | 1989-04-27 | 1994-03-08 | The Board Of Governors Of The University | Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same |
EP0749321B1 (en) * | 1994-02-09 | 2007-01-24 | Epitopix LLC | Active immunization using a siderophore receptor protein |
US5830479A (en) * | 1994-02-09 | 1998-11-03 | Willmar Poultry Company, Inc. | Active immunization using a siderophore receptor protein |
US5538733A (en) * | 1994-07-07 | 1996-07-23 | Willmar Poultry Company, Inc. | Method of priming an immune response in a one-day old animal |
US6403337B1 (en) * | 1996-01-05 | 2002-06-11 | Human Genome Sciences, Inc. | Staphylococcus aureus genes and polypeptides |
CA2255669A1 (en) * | 1996-05-16 | 1997-11-20 | The Texas A & M University System | Collagen binding protein compositions and methods of use |
US6680195B1 (en) * | 1997-11-26 | 2004-01-20 | Inhibitex, Inc. | Extracellular matrix-binding proteins from staphylococcus aureus |
US6703025B1 (en) * | 1998-08-31 | 2004-03-09 | Inhibitex, Inc. | Multicomponent vaccines |
US6692739B1 (en) * | 1998-08-31 | 2004-02-17 | Inhibitex, Inc. | Staphylococcal immunotherapeutics via donor selection and donor stimulation |
US6682754B2 (en) | 1999-11-24 | 2004-01-27 | Willmar Poultry Company, Inc. | Ovo delivery of an immunogen containing implant |
KR20020097200A (ko) | 2000-03-21 | 2002-12-31 | 엘리트라 파마슈티컬즈, 인코포레이티드 | 원핵세포에서의 필수유전자의 동정 |
AT410173B (de) * | 2000-06-08 | 2003-02-25 | Cistem Biotechnologies Gmbh | Antigene zusammensetzung |
NZ526786A (en) * | 2001-01-03 | 2006-02-24 | Willmar Poultry Co Inc | Methods for removal of lipopolysaccharides (LPS) from vaccines for non-human animals |
AT410798B (de) | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
GB0107661D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Staphylococcus aureus |
JP4424984B2 (ja) * | 2001-06-15 | 2010-03-03 | インヒビテックス インコーポレーテッド | コアグラーゼ陰性ブドウ球菌および黄色ブドウ球菌由来の表面蛋白質を認識する、交差反応性モノクローナルおよびポリクローナル抗体 |
WO2003020875A2 (en) | 2001-06-17 | 2003-03-13 | D-Squared Biotechnologies, Inc. | Staphylococci surface-exposed immunogenic polypeptides |
US6720160B2 (en) * | 2001-10-11 | 2004-04-13 | Helica Biosystems, Inc. | Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals |
AU2003254555A1 (en) | 2002-07-26 | 2004-02-23 | Intercell Ag | S. aureus antigene |
US6947260B2 (en) * | 2002-11-18 | 2005-09-20 | Hitachi Global Storage Technologies Netherlands B.V. | System and method of damping vibration on coil supports in high performance disk drives with rotary actuators |
ES2395022T3 (es) * | 2003-09-19 | 2013-02-07 | Epitopix, Llc | Polipéptidos de Campylobacter y sus métodos de uso |
US20070128183A1 (en) * | 2004-04-27 | 2007-06-07 | Intercell Ag | Td antigens |
EP1784220B1 (en) | 2004-08-26 | 2017-12-20 | The University Of Western Ontario | Bacterial iron acquisition targets |
WO2006059247A2 (en) | 2004-10-25 | 2006-06-08 | The University Of Western Ontario | VACCINES, COMPOSITIONS AND METHODS BASED ON STAPHYLOCOCCUS AUREUS IRON-REGULATED SURFACE DETERMINANTS IsdA, IsdB, and IsdC |
ES2586125T3 (es) | 2005-02-14 | 2016-10-11 | Epitopix, Llc | Polipéptidos de Staphylococcus aureus y métodos de uso |
MX339461B (es) | 2009-03-23 | 2016-05-27 | Epitopix Llc | Polipeptidos y composiciones inmunizantes que contienen polipeptidos grampositivos y metodos de uso. |
-
2006
- 2006-02-14 ES ES06734951.4T patent/ES2586125T3/es active Active
- 2006-02-14 DK DK06734951.4T patent/DK1853306T3/en active
- 2006-02-14 CA CA2597263A patent/CA2597263C/en active Active
- 2006-02-14 EP EP06734951.4A patent/EP1853306B1/en active Active
- 2006-02-14 WO PCT/US2006/005058 patent/WO2006088803A2/en active Application Filing
- 2006-02-14 NZ NZ560612A patent/NZ560612A/en not_active IP Right Cessation
- 2006-02-14 MX MX2007009828A patent/MX2007009828A/es active IP Right Grant
- 2006-02-14 AU AU2006214534A patent/AU2006214534B2/en not_active Ceased
- 2006-02-14 CN CN201310020750.0A patent/CN103143006B/zh not_active Expired - Fee Related
- 2006-02-14 CN CN2006800049030A patent/CN101119744B/zh not_active Expired - Fee Related
- 2006-02-14 JP JP2007555321A patent/JP2008532935A/ja not_active Withdrawn
- 2006-02-14 NZ NZ597997A patent/NZ597997A/xx not_active IP Right Cessation
- 2006-02-14 BR BRPI0607323A patent/BRPI0607323B8/pt active IP Right Grant
- 2006-02-14 NZ NZ589238A patent/NZ589238A/en not_active IP Right Cessation
- 2006-02-14 NZ NZ613923A patent/NZ613923A/en not_active IP Right Cessation
- 2006-02-14 US US11/353,459 patent/US8007811B2/en active Active
- 2006-09-11 US US11/518,727 patent/US8025885B2/en active Active
- 2006-09-11 US US11/518,689 patent/US8007803B2/en active Active
-
2008
- 2008-03-18 US US12/077,268 patent/US8709436B2/en active Active
- 2008-08-07 HK HK08108684.6A patent/HK1117746A1/xx not_active IP Right Cessation
- 2008-11-17 US US12/272,021 patent/US8709760B2/en active Active
-
2012
- 2012-01-31 US US13/362,992 patent/US8961979B2/en active Active
- 2012-12-05 JP JP2012266189A patent/JP2013053155A/ja not_active Withdrawn
-
2013
- 2013-07-01 US US13/932,877 patent/US20140005360A1/en not_active Abandoned
- 2013-07-01 US US13/932,863 patent/US20130280300A1/en not_active Abandoned
- 2013-07-01 US US13/932,870 patent/US20130288952A1/en not_active Abandoned
- 2013-07-01 US US13/932,875 patent/US20130287813A1/en not_active Abandoned
-
2015
- 2015-01-29 US US14/608,493 patent/US9266944B2/en active Active
- 2015-05-01 JP JP2015094191A patent/JP6100826B2/ja active Active
-
2016
- 2016-02-15 US US15/043,740 patent/US9623076B2/en active Active
-
2017
- 2017-03-09 US US15/454,197 patent/US9981028B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0607323A2 (pt) | composições e uso de polipeptìdeos e kits para a detecção de anticorpo que se liga especificamente a um polipeptìdeo | |
CY1121291T1 (el) | Ανοσοδοκιμασιες ενισχυσης σηματος | |
CY1124802T1 (el) | Δεσμευτικοι παραγοντες σκληροστινης | |
BRPI0606506A2 (pt) | polipeptìdeos de yersinia spp. e métodos de uso | |
CY1120951T1 (el) | Ανθρωπινα αντισωματα enanti-tau | |
EA200970210A1 (ru) | Prlr-специфическое антитело и его применения | |
MX2007010349A (es) | Composiciones y metodos para clasificar muestras biologicas. | |
CR20160206A (es) | Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento C5 | |
ECSP088543A (es) | Anticuerpos anti-ox40l y métodos que los utilizan | |
ECSP099027A (es) | Anticuerpos anti-dll4 y métodos que los usan | |
BR112013023540A2 (pt) | anticorpo, kit e método para a determinação de peptídeos amilóides | |
AR057237A1 (es) | Metodos y composiciones para actuar sobre la poliubiquitina | |
BRPI0812878B8 (pt) | anticorpo isolado ou parte funcional do mesmo, vetor, método para produzir um anticorpo ou uma parte funcional do mesmo, para produzir uma célula produtora de anticorpo e para produzir um anticorpo capaz de se ligar especificamente a rsv, composição, e, uso de um anticorpo ou parte funcional do mesmo ou de uma composição ou de vetor | |
BRPI0514672A (pt) | polipeptìdeos de fusobacterium e métodos de uso | |
BRPI0909044B8 (pt) | anticorpo que se liga especificamente ao csf-1r humano,composição farmacêutica e uso dos mesmos | |
DE602006015793D1 (de) | Proteolipidmembran und lipidmembranen-biosensor | |
ATE476655T1 (de) | Doxorubicin-immuntest | |
DE602006007967D1 (de) | Gegen das gemeinsame epitop von mutierten p53 gerichtete humane synthetische einzelkettenantikörper und anwendungen davon | |
EA200702361A1 (ru) | АНТИТЕЛА ПРОТИВ csPCNA ИЗОФОРМЫ И ИХ ПРИМЕНЕНИЕ | |
WO2009007846A3 (en) | Methods for modifying, isolating, detecting, visualizing, and quantifying citrullinated and/or homocitrullinated peptides, polypeptides and proteins | |
ATE489623T1 (de) | Peptide zum nachweis von ehrlichia ewingii antikörper | |
DK2021794T3 (da) | Anvendelse af protein S100A 12 som en markør for colorektal cancer | |
AR059096A1 (es) | Anticuerpos anti- efrina -b2 y metodos que usan estos | |
BR112012019475A2 (pt) | "uso de um anticorpo monoclonal anti-cd 44 anticorpo anti-cd44 humanizado e kit para a detecção da presença de hnscc em uma amostra | |
DK1987357T3 (da) | Polypeptider, som genkendes af anti-Trichinella-antistoffer, og anvendelser deraf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/12/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/02/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |